110 related articles for article (PubMed ID: 20088148)
1. A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis.
Dunn JD; Pill MW
Manag Care; 2009 Dec; 18(12):44-50. PubMed ID: 20088148
[TBL] [Abstract][Full Text] [Related]
2. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
3. Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation.
Iyer S; Davis KL; Candrilli S
Manag Care; 2010 Mar; 19(3):44-51. PubMed ID: 20361548
[TBL] [Abstract][Full Text] [Related]
4. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of congestive heart failure in a managed care population.
Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
7. Projecting corporate health plan utilization and charges from annual ICD-9-CM diagnostic rates: a value-added opportunity for pathologists.
Elevitch FR; Silvers A; Sahl JD
Arch Pathol Lab Med; 1997 Nov; 121(11):1187-91. PubMed ID: 9372747
[TBL] [Abstract][Full Text] [Related]
8. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
9. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
Lee J; Cummins G; Okamoto L
Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
[TBL] [Abstract][Full Text] [Related]
10. The health care status of the diabetic population as reflected by physician claims to a major insurer.
Rendell M; Kimmel DB; Bamisedun O; O'Donnell ET; Fulmer J
Arch Intern Med; 1993 Jun; 153(11):1360-6. PubMed ID: 8507126
[TBL] [Abstract][Full Text] [Related]
11. Finasteride versus dutasteride: a real-world economic evaluation.
Fenter TC; Runken MC; Black L; Eaddy M
Am J Manag Care; 2007 Feb; 13 Suppl 1():S23-8. PubMed ID: 17295602
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization associated with dyspepsia in patients with arthritis.
Zhao SZ; Arguelles LM; Dedhiya SD; Morgan DG
Am J Manag Care; 1999 Oct; 5(10):1285-95. PubMed ID: 10622994
[TBL] [Abstract][Full Text] [Related]
13. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
15. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
[TBL] [Abstract][Full Text] [Related]
16. Challenges of estimating health service utilization for osteoarthritis patients on a population level.
Harrold LR; Yood RA; Straus W; Andrade SE; Reed JI; Cernieux J; Lewis BE; Gurwitz JH
J Rheumatol; 2002 Sep; 29(9):1931-6. PubMed ID: 12233888
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs associated with osteoarthritis in US patients.
Le TK; Montejano LB; Cao Z; Zhao Y; Ang D
Pain Pract; 2012 Nov; 12(8):633-40. PubMed ID: 22309128
[TBL] [Abstract][Full Text] [Related]
19. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
Hoy T; Singhal PK; Willey VJ; Insinga RP
Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
[TBL] [Abstract][Full Text] [Related]
20. Costs attributable to osteoarthritis.
MacLean CH; Knight K; Paulus H; Brook RH; Shekelle PG
J Rheumatol; 1998 Nov; 25(11):2213-8. PubMed ID: 9818666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
